Ambu A/S (AMBU B:CPH) - Strategic SWOT and Financial Analysis
Ambu A/S (AMBU B:CPH) - Strategic SWOT and Financial Analysis - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Financial and Operational KPI’s, and Recent Trends
Ambu A/S (AMBU B:CPH)の戦略的SWOTと財務分析:機会、課題、リスクの360度レビュー、企業とESG戦略、競合情報、財務と経営KPW、最新動向
| 出版 | Quaintel Research |
| 出版年月 | 2026年6月 |
| ページ数 | 134 |
| シングルユーザ | USD 150.00 |
| 企業ライセンス | USD 195.00 |
Report Overview
Report Summary
Ambu A/S Strategic SWOT Analysis and Financial Insights – A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends Report is a comprehensive and easily accessible overview of Ambu A/S’s business operations. It provides a detailed analysis of the company’s financial and strategic standing, as well as its position in the industry compared to competitors. The report includes several key features to facilitate decision-making and provide insights into the company’s performance.
The report begins with in-depth information about Ambu A/S including key insights, business segments, key executives, locations, products and services, historical events, corporate strategy, and management discussions. This section provides a solid foundation for understanding the company’s key attributes.
Next, the report assesses Ambu A/S’s strategic standing through various analyses. The ESG spotlight evaluates the company’s environmental, social, and governance performance, providing insights into its sustainability efforts and ethical practices. The SWOT analysis examines the company’s internal strengths and weaknesses, as well as external opportunities and threats. Additionally, By integrating these strategic analyses, the report offers a comprehensive understanding of Ambu A/S’s overall strategic standing and supports informed decision-making and strategic planning.
The report also covers Ambu A/S’s financial analysis basis of latest income statement, balance sheet, and cash flow statement. Key financial ratios related to profitability, asset turnover, credit, market, and long-term solvency are outlined, providing guidance for investment decisions. Furthermore, the report compares Ambu A/S’s financial parameters with those of its competitors, offering a unique analysis of the competitive landscape. This information helps manage the business environment and improve sales activities by gaining insight into competitors’ operations.
Finally, the report includes recent news and deal activities undertaken by Ambu A/S enhancing awareness of the company’s business trends, growth perspectives, and more.
Key Highlights
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. It provides healthcare solutions in the fields of visualization, anesthesia, and patient monitoring and diagnostics. The company offers endoscopy products, such as bronchoscopes and monitors; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products consisting of ECG electrodes; and airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers extrication collars, CPR breathing barriers, video laryngoscopes, and training manikins. Ambu A/S was founded in 1937 and is headquartered in Ballerup, Denmark.
Ambu A/S in the News:-
2025-06-19 – Ambu obtains FDA clearance for first-ever single-use flexible cysto-nephroscopy solution
2025-06-02 – Ambu launches first-of-its-kind endoscope recycling program to enhance waste reduction in hospitals
2025-05-16 – Reporting of transactions made by persons dischargingmanagerial responsibilities
2025-05-12 – Ambu® SureSight™ Connect video laryngoscope expands with paediatric blade options
2025-02-19 – Ambu expands CE mark for existing urology solution, enables new type of procedure
Scope
• Tactical Analysis:- Various strategic frameworks to gain insights into a Ambu A/S’s competitive position and operational environment. These analytical tools assist in identifying competitive advantages, potential risks, and areas for improvement and efficiency, enabling companies to make informed tactical decisions.
• Business Strategy:- Contributes to shaping the Ambu A/S’s overall direction, goals, and decision-making processes, ensuring long-term success and alignment with stakeholder expectations.
• Financial Position:- Provide valuable information on the financial performance and investor sentiment surrounding the company. Indicating the level of confidence and expectations in the company’s future prospects. These components collectively contribute to understanding the financial health and market perception of the company.
• Company Fundamentals:- These fundamentals offer valuable insights into the company’s history, operations, leadership, and geographical presence, aiding in a comprehensive understanding of the organization.
• Competitive Landscape:- An identification of the Ambu A/S’s main competitors, providing insights into the competitive landscape it operates in.
Reasons to Buy
• Comprehensive Understanding of the Ambu A/S’s internal and external factors through SWOT analysis, Financial Analysis, and Competitors Benchmarking.
• Strive Strategic Decision Making with various analyses and identifying potential customers and suppliers.
• Mitigate Risk with help of thorough analysis of internal and external factors. Furthermore, develop strategies and contingency plans to address these challenges and minimize their impact on business operations.
• Competitive Benchmarking will help to gain a competitive advantage by understanding industry trends, customer preferences, and best practices.
• Financial Performance Evaluation provides crucial insights into key financial ratios and trends, supporting better financial decision-making and resource allocation.
• Valuable insights from the report enable investors and partners to make informed decisions regarding potential Collaborations, Investments, or Partnerships with the company.
Additionally, available deep-dive analysis on the company Ambu A/S:
• Ambu A/S PESTLE Analysis
• Ambu A/S Value Chain Analysis
• Ambu A/S Porter’s Five Forces Analysis
• Ambu A/S VRIO Analysis
• Ambu A/S BCG Analysis
• Ambu A/S Segmentation, Targeting and Positioning (STP) Analysis
• Ambu A/S Ansoff Matrix Analysis
Table of Contents
Table of Contents 2
Tables 5
Charts 6
Ambu A/S – Key Company Facts 7
Ambu A/S – Company Description 8
Ambu A/S – Top Executives 9
Ambu A/S – Head Office & Locations 10
Head Office – Country 10
Ambu A/S – Products and Services 11
Products 11
Services 12
Ambu A/S – Corporate Strategy 13
Ambu A/S – Business Description 16
Medical Technology Solutions 16
Ambu A/S – ESG Spotlight 18
Environment 18
Social 19
Corporate Governance 19
Ambu A/S – SWOT Analysis 21
Overview 21
Strengths 23
Weaknesses 26
Opportunities 28
Threats 30
Ambu A/S – Financial Deep Dive 32
Share Price Trend – Jun-2025 to Jun-2026 (Average Share Closing Price) 32
Profit and Loss Statement 34
Summary of Profit and Loss Statement 34
Balance Sheet 38
Summary of Balance Sheet 38
Cash Flow Statement 42
Summary of Cash Flow Statement 42
Key Financial Ratio Analysis 46
Ambu A/S – Ratio Charts 48
Activity Ratio Charts 48
Growth Ratios Charts 49
Leverage Ratio Charts 53
Liquidity Ratio Charts 55
Profitability Ratio Charts 57
Competing Players 59
Snapshot of Competing Players 60
Abbott Laboratories 60
Key Company Facts 60
Company Description 60
Abbott Laboratories – SWOT Spotlight 61
Abbott Laboratories – PESTLE Spotlight 63
Key Financials 66
Share Price Trend – Jun-2025 to Jun-2026 (Average Share Closing Price) 66
Key Financial Ratio Analysis 71
Boston Scientific Corporation 73
Key Company Facts 73
Company Description 73
Boston Scientific Corporation – SWOT Spotlight 74
Boston Scientific Corporation – PESTLE Spotlight 76
Key Financials 78
Share Price Trend – Jun-2025 to Jun-2026 (Average Share Closing Price) 78
Key Financial Ratio Analysis 83
HOYA Corporation 85
Key Company Facts 85
Company Description 85
Key Financials 86
Share Price Trend – Jun-2025 to Jun-2026 (Average Share Closing Price) 86
Key Financial Ratio Analysis 91
Medtronic plc 93
Key Company Facts 93
Company Description 93
Medtronic plc – SWOT Spotlight 94
Medtronic plc – PESTLE Spotlight 96
Key Financials 98
Share Price Trend – Jun-2025 to Jun-2026 (Average Share Closing Price) 98
Key Financial Ratio Analysis 103
Olympus Corporation 105
Key Company Facts 105
Company Description 105
Olympus Corporation – SWOT Spotlight 106
Olympus Corporation – PESTLE Spotlight 108
Key Financials 110
Share Price Trend – Jun-2025 to Jun-2026 (Average Share Closing Price) 110
Key Financial Ratio Analysis 115
Ambu A/S – In the News 117
19-Jun-2025 – Ambu obtains FDA clearance for first-ever single-use flexible cysto-nephroscopy solution 117
Appendix 118
Definitions 118
SWOT Analysis 118
PESTLE Analysis 118
Value Chain Analysis 118
ESG Spotlight 118
Financial Deep Dive 118
Financial Ratios 119
Activity Ratios 119
Growth Ratios 121
Leverage Ratios 124
Liquidity Ratios 126
Market Ratios 128
Profitability Ratios 130
Research Methodology 132
Disclaimer 133
Contact Us 133
List of Tables
Table 1: Ambu A/S – Company Facts 7
Table 2: Ambu A/S – Digital Presence 7
Table 3: Ambu A/S – Top Executives 9
Table 4: Ambu A/S – Products 11
Table 5: Ambu A/S – Services 12
Table 6: Ambu A/S – Share Price Trend – Jun-2025 to Jun-2026 32
Table 7: Ambu A/S – Profit and Loss Statement – 2022-2025 35
Table 8: Ambu A/S – Balance Sheet – 2022-2025 39
Table 9: Ambu A/S – Cash Flow Statement – 2022-2025 43
Table 10: Ambu A/S – Ratio Analysis – 2022-2025 46
Table 11: Ambu A/S – Competing Players 59
Table 12: Competing Players – Abbott Laboratories – Key Company Facts 60
Table 13: Abbott Laboratories – Share Price Trend – Jun-2025 to Jun-2026 66
Table 14: Competing Players – Abbott Laboratories – Profit and Loss Statement – 2022-2025 68
Table 15: Abbott Laboratories – Balance Sheet 2022-2025 69
Table 16: Abbott Laboratories – Cash Flow Statement 2022-2025 70
Table 17: Abbott Laboratories – Ratio Analysis – 2022-2025 71
Table 18: Competing Players – Boston Scientific Corporation – Key Company Facts 73
Table 19: Boston Scientific Corporation – Share Price Trend – Jun-2025 to Jun-2026 78
Table 20: Competing Players – Boston Scientific Corporation – Profit and Loss Statement – 2022-2025 80
Table 21: Boston Scientific Corporation – Balance Sheet 2022-2025 81
Table 22: Boston Scientific Corporation – Cash Flow Statement 2022-2025 82
Table 23: Boston Scientific Corporation – Ratio Analysis – 2022-2025 83
Table 24: Competing Players – HOYA Corporation – Key Company Facts 85
Table 25: HOYA Corporation – Share Price Trend – Jun-2025 to Jun-2026 86
Table 26: Competing Players – HOYA Corporation – Profit and Loss Statement – 2023-2026 88
Table 27: HOYA Corporation – Balance Sheet 2023-2026 89
Table 28: HOYA Corporation – Cash Flow Statement 2023-2026 90
Table 29: HOYA Corporation – Ratio Analysis – 2023-2026 91
Table 30: Competing Players – Medtronic plc – Key Company Facts 93
Table 31: Medtronic plc – Share Price Trend – Jun-2025 to Jun-2026 98
Table 32: Competing Players – Medtronic plc – Profit and Loss Statement – 2022-2025 100
Table 33: Medtronic plc – Balance Sheet 2022-2025 101
Table 34: Medtronic plc – Cash Flow Statement 2022-2025 102
Table 35: Medtronic plc – Ratio Analysis – 2022-2025 103
Table 36: Competing Players – Olympus Corporation – Key Company Facts 105
Table 37: Olympus Corporation – Share Price Trend – Jun-2025 to Jun-2026 110
Table 38: Competing Players – Olympus Corporation – Profit and Loss Statement – 2023-2026 112
Table 39: Olympus Corporation – Balance Sheet 2023-2026 113
Table 40: Olympus Corporation – Cash Flow Statement 2023-2026 114
Table 41: Olympus Corporation – Ratio Analysis – 2023-2026 115
List of Figures
Figure 1: Ambu A/S – SWOT Analysis 22
Figure 2: Ambu A/S – Average Share Price Trend – Jun-2025 to Jun-2026 33
Figure 3: Ambu A/S – Profit and Loss Statement – 2022-2025 37
Figure 4: Ambu A/S – Balance Sheet – 2022-2025 41
Figure 5: Ambu A/S – Cash Flow Statement 2022-2025 45
Figure 6: Ambu A/S – Activity Ratio Charts 48
Figure 7: Ambu A/S – Growth Ratio Charts (Value %) 49
Figure 8: Ambu A/S – Leverage Ratio Charts 53
Figure 9: Ambu A/S – Liquidity Ratio Charts 55
Figure 10: Ambu A/S – Profitability Ratio Charts (Value %) 57
Figure 11: Competing Players – Abbott Laboratories – SWOT Spotlight 62
Figure 12: Competing Players – Abbott Laboratories – PESTLE Spotlight 65
Figure 13: Abbott Laboratories – Average Share Price Trend – Jun-2025 to Jun-2026 67
Figure 14: Abbott Laboratories – Profit and Loss Statement – 2022-2025 68
Figure 15: Abbott Laboratories – Balance Sheet – 2022-2025 69
Figure 16: Abbott Laboratories – Cash Flow Statement 2022-2025 70
Figure 17: Competing Players – Boston Scientific Corporation – SWOT Spotlight 75
Figure 18: Competing Players – Boston Scientific Corporation – PESTLE Spotlight 77
Figure 19: Boston Scientific Corporation – Average Share Price Trend – Jun-2025 to Jun-2026 79
Figure 20: Boston Scientific Corporation – Profit and Loss Statement – 2022-2025 80
Figure 21: Boston Scientific Corporation – Balance Sheet – 2022-2025 81
Figure 22: Boston Scientific Corporation – Cash Flow Statement 2022-2025 82
Figure 23: HOYA Corporation – Average Share Price Trend – Jun-2025 to Jun-2026 87
Figure 24: HOYA Corporation – Profit and Loss Statement – 2023-2026 88
Figure 25: HOYA Corporation – Balance Sheet – 2023-2026 89
Figure 26: HOYA Corporation – Cash Flow Statement 2023-2026 90
Figure 27: Competing Players – Medtronic plc – SWOT Spotlight 95
Figure 28: Competing Players – Medtronic plc – PESTLE Spotlight 97
Figure 29: Medtronic plc – Average Share Price Trend – Jun-2025 to Jun-2026 99
Figure 30: Medtronic plc – Profit and Loss Statement – 2022-2025 100
Figure 31: Medtronic plc – Balance Sheet – 2022-2025 101
Figure 32: Medtronic plc – Cash Flow Statement 2022-2025 102
Figure 33: Competing Players – Olympus Corporation – SWOT Spotlight 107
Figure 34: Competing Players – Olympus Corporation – PESTLE Spotlight 109
Figure 35: Olympus Corporation – Average Share Price Trend – Jun-2025 to Jun-2026 111
Figure 36: Olympus Corporation – Profit and Loss Statement – 2023-2026 112
Figure 37: Olympus Corporation – Balance Sheet – 2023-2026 113
Figure 38: Olympus Corporation – Cash Flow Statement 2023-2026 114
